Travere Therapeutics
Price & Volume
Stats
See more52W Range | $12.91-$42.13 |
Market Cap | $2.6B |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $490.7M |
Revenue Growth (YoY) | 73.4% |
Gross Profit (12 Mos) | $274.3M |
Diluted EPS | -$1.03 |
News
See moreYahoo Finance • 4 days ago
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory
Yahoo Finance • 4 days ago
Travere Therapeutics (TVTX) Reports 144% Annual Growth in Filspari Sales for 2025
Yahoo Finance • 8 days ago
Travere outlines FILSPARI-driven growth and new FSGS milestone as 2026 begins
Yahoo Finance • 11 days ago
Is Travere Therapeutics (TVTX) Still Attractive After Recent Share Price Volatility?
About
CEO | Dr. Eric M. Dube Ph.D. |
Address | 3611 Valley Centre Drive, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 497 |
